Reports

Biotech Growth Stock Disrupting Skin Cancer Treatments

Medicus Pharma's microneedle patch targets a $15B skin cancer market with a non-invasive, cost-effective alternative to surgery and FDA Fast-Track potential.

The Salt Project Shaping up to be a Huge North American Asset

Atlas Salt presents a compelling defensive stock opportunity driven by strong market demand, necessary mining infrastructure, and sustainable growth potential.

Tech Demand Growth Drives Investors Toward Graphite Stocks

Graphite is a critical mineral vital to the renewable energy revolution. Graphite One Inc. brings a graphite investment opportunity to North American investors.